These findings are in line with a previous report demonstrating reduced atherosclerosis burden in ApoE–/– mice with specific PAD4 deletion in the myeloid lineage (23) and further support the prominent role of PAD4 in lesion progression. The gene discussed is PADI4; the disease is atherosclerosis.